AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Geneglim M 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Genezen Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Geneglim M 1mg/500mg Tablet ER

Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate blood glucose, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. The most prevalent adverse effect of Diabexe Duo is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, lightheadedness, headache, tremors—and know how to address them. Regular meals and carrying a rapid-acting glucose source (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiac issues should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Geneglim M 1mg/500mg Tablet ER

No text was provided to rewrite.

Uses of Geneglim M 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Geneglim M 1mg/500mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Geneglim M 1mg/500mg Extended-Release Tablet with food.

Common Side effects of Geneglim M 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Geneglim M 1mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Geneglim M 1mg/500mg Extended-Release tablet should be taken with a meal.

How Geneglim M 1mg/500mg Tablet ER works:

Geneglim M 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Geneglim M 1mg/500mg Extended-Release Tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Geneglim M 1mg/500mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Geneglim M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Geneglim M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. For patients with severe kidney disease, this medication is contraindicated. Close monitoring of kidney function is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Geneglim M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Geneglim M 1mg/500mg Tablet ER :

Should you forget a dose of Geneglim M 1mg/500mg Extended-Release Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Geneglim M 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Geneglim M 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Geneglim M 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention, including discontinuing Geneglim M, if these symptoms occur.
Geneglim M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Geneglim M 1mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Geneglim M 1mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Geneglim M 1mg/500mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Geneglim M 1mg/500mg ER tablets with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia, and may increase the risk of lactic acidosis.
Geneglim M 1mg/500mg Tabl...
55
MRP 67
17% off